comparemela.com

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.

Related Keywords

Martin Franklin ,Irwin Simon ,Nikola Corporation ,Pacwest Bancorp ,Moonlake Immunotherapeutics ,Belite Bio Inc ,Aston Martin ,Nasdaq ,Babylon Holdings Limited ,Ironnet Inc ,Earth Brands Inc ,Acelyrin Inc ,Kubient Inc ,Bioscience Inc ,Oneconnect Financial Technology Co Ltd ,Super League Gaming Inc ,Mercury Systems Inc ,Lucid Group Inc ,Biorestorative Therapies Inc ,Gsr Ii Meteora Acquisition Corp ,Sl Green Realty Corp ,Path Holdings Inc ,Identiv Inc ,Collplant Biotechnologies Ltd ,Biomea Fusion Inc ,Media Brands Inc ,Scworx Corp ,Nauticus Robotics Inc ,Ionq Inc ,Fibrogen Inc ,Better Choice Company Inc ,Super Group ,Avalo Therapeutics Inc ,Doma Holdings Inc ,Bruush Oral Care Inc ,Benitec Biopharma Inc ,Surgalign Holdings Inc ,Intapp Inc ,Altice United States Inc ,Hitek Global Inc ,Lulu Fashion Lounge Holdings Inc ,Superlatus Inc ,Pharmaceuticals Inc ,Digital Media Solutions Inc ,Trxade Health Inc ,Mindmaze Group ,Scholar Rock Holding Corporation ,Pieris Pharmaceuticals Inc ,Skillz Inc ,Genesco Inc ,Digital Media Solutions ,Lion Group Holding Ltd ,Femasys Inc ,Oculopharyngeal Muscular ,Media Brands ,Media Solutions ,Restorative Therapies ,Earth Brands ,Executive Chairman ,Whole Earth ,League Gaming ,United States ,Ares Management ,Fashion Lounge Holdings ,Russell Microcap ,Healthcare Trust ,Path Holdings ,Albacore Capital ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.